Concepedia

Xuan Beatty

XB

Statistics

Publications

2

Citations

465

H-Index

2

Active since

2018

Affiliations

Miragen Therapeutics (United States)(Current)

Xuan Beatty is an author at Miragen Therapeutics (United States) specializing in microrna regulation in cancer, molecular oncology, and medicine.

Publications per year

2018–2020

2

Publications

2

Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma

Anita G. Seto, Xuan Beatty, Joshua M. Lynch et al. · British Journal of Haematology · 2018 · 315 citations · Full text

, , +15

Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth <i>In Vitro</i> and <i>In Vivo</i>

Eleni Anastasiadou, Anita G. Seto, Xuan Beatty et al. · Clinical Cancer Research · 2020 · 150 citations · Full text

, , +14

1–2 of 2